These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16783150)

  • 21. [Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
    Walochnik J; Duchêne M; Eibl H; Aspöck H
    Wien Klin Wochenschr; 2003; 115 Suppl 3():10-7. PubMed ID: 15508774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acanthamoeba keratitis: about the first two Tunisian cases].
    Ben Salah S; Makni F; Cheikrouhou F; Ben Zina Z; Mlik M; Feki J; Colin J; Ayadi A
    Bull Soc Pathol Exot; 2007 Feb; 100(1):41-2. PubMed ID: 17402694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.
    Murdoch D; Gray TB; Cursons R; Parr D
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):231-6. PubMed ID: 9717755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of topical corticosteroids in the management of Acanthamoeba keratitis.
    Park DH; Palay DA; Daya SM; Stulting RD; Krachmer JH; Holland EJ
    Cornea; 1997 May; 16(3):277-83. PubMed ID: 9143798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical treatment for combined Fusarium and Acanthamoeba keratitis.
    Lin HC; Hsiao CH; Ma DH; Yeh LK; Tan HY; Lin MY; Huang SC
    Acta Ophthalmol; 2009 Mar; 87(2):199-203. PubMed ID: 18507727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy in a murine model of Acanthamoeba keratitis.
    Ruddell TJ; Easty DL
    Eye (Lond); 1995; 9 ( Pt 1)():142-3. PubMed ID: 7713244
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
    Larkin DF; Kilvington S; Dart JK
    Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.
    Rama P; Matuska S; Viganò M; Spinelli A; Paganoni G; Brancato R
    Eur J Ophthalmol; 2003 Apr; 13(3):311-4. PubMed ID: 12747654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
    Vaquero Ruano M; Encinas Martín JL; Ramón Y Cajal S; Cajigal Morales C
    Arch Soc Esp Oftalmol; 2002 May; 77(5):279-81. PubMed ID: 12023748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
    Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
    Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acanthamoeba lenticulata keratitis in a hard contact lens wearer.
    van Zyl LM; Andrew N; Chehade M; Sadlon TA; Badenoch PR
    Clin Exp Ophthalmol; 2013 Nov; 41(8):810-2. PubMed ID: 23448683
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
    Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
    Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of early Acanthamoeba keratitis with alcohol-assisted epithelial debridement.
    Li ML; Shih MH; Huang FC; Tseng SH; Chen CC
    Cornea; 2012 Apr; 31(4):442-6. PubMed ID: 22236786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
    Narasimhan S; Madhavan HN; K LT
    Cornea; 2002 Mar; 21(2):203-5. PubMed ID: 11862096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Painless Acanthamoeba Keratitis with Normal Vision.
    Kwok PW; Kam KW; Jhanji V; Young AL
    Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
    Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
    Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.